|
FZD5 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.513000E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.217400E-01 |
| Normal-vs-Stage2 |
7.746000E-01 |
| Normal-vs-Stage3 |
1.255210E-01 |
| Normal-vs-Stage4 |
1.544440E-01 |
| Stage1-vs-Stage2 |
2.525800E-01 |
| Stage1-vs-Stage3 |
2.330200E-02 |
| Stage1-vs-Stage4 |
8.107600E-02 |
| Stage2-vs-Stage3 |
2.825000E-01 |
| Stage2-vs-Stage4 |
1.421040E-01 |
| Stage3-vs-Stage4 |
5.475800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.827000E-01 |
| Normal-vs-AfricanAmerican |
7.066200E-01 |
| Normal-vs-Asian |
4.359600E-01 |
| Caucasian-vs-AfricanAmerican |
7.425200E-01 |
| Caucasian-vs-Asian |
4.134400E-01 |
| AfricanAmerican-vs-Asian |
3.882200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.117200E-01 |
| Normal-vs-Female |
3.263600E-01 |
| Male-vs-Female |
7.635700E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.924800E-01 |
| Normal-vs-Extreme_Weight |
1.235230E-01 |
| Normal-vs-Obese |
4.754000E-01 |
| Normal-vs-Extreme_Obese |
9.677000E-01 |
| Normal_Weight-vs-Extreme_Weight |
7.790000E-01 |
| Normal_Weight-vs-Obese |
7.936200E-02 |
| Normal_Weight-vs-Extreme_Obese |
4.754400E-01 |
| Extreme_Weight-vs-Obese |
1.591620E-02 |
| Extreme_Weight-vs-Extreme_Obese |
3.073000E-01 |
| Obese-vs-Extreme_Obese |
7.197400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.071700E-02 |
| Normal-vs-Age(41-60Yrs) |
6.819800E-01 |
| Normal-vs-Age(61-80Yrs) |
1.492000E-01 |
| Normal-vs-Age(81-100Yrs) |
4.706400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.511900E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.163880E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.711600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.098100E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.832000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.335700E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.524600E-01 |
| Normal-VS-Type2 PRCC |
6.047000E-01 |
| Normal-VS-KIRP CIMP |
4.499300E-03 |
| Normal-VS-Unclassified PRCC |
6.277800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
9.654400E-02 |
| Type1 PRCC-VS-KIRP CIMP |
2.543500E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
2.105400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.588530E-04 |
| Type2 PRCC-VS-Unclassified PRCC |
9.365000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.182440E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.732400E-01 |
| Normal-vs-N1 |
8.978900E-03 |
| Normal-vs-N2 |
3.443200E-01 |
| N0-vs-N1 |
8.818700E-03 |
| N0-vs-N2 |
4.183600E-01 |
| N1-vs-N2 |
5.313200E-01 |
|
|
